Outset Medical Inc. (OM)
NASDAQ: OM
· Real-Time Price · USD
19.43
0.93 (5.03%)
At close: May 15, 2025, 3:59 PM
19.45
0.13%
After-hours: May 15, 2025, 07:59 PM EDT
Outset Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Consoles Product Revenue | 29.83M | 61.33M | 64.59M | 65.13M | 6.74M |
| Consoles Product Revenue Growth | -51.36% | -5.05% | -0.83% | +866.08% | n/a |
| Consumables Product Revenue | 51.15M | 42.21M | 28.8M | 19.18M | 39.61M |
| Consumables Product Revenue Growth | +21.18% | +46.56% | +50.15% | -51.58% | n/a |
| Product Revenue | 80.98M | 103.54M | 93.39M | 84.31M | 10.32M |
| Product Revenue Growth | -21.79% | +10.87% | +10.76% | +716.74% | n/a |
| Service And Other Revenue Revenue | 32.71M | 26.84M | 21.99M | 18.29M | n/a |
| Service And Other Revenue Revenue Growth | +21.88% | +22.07% | +20.21% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 24.72M | 25.52M | 30.81M | 32.49M | 32.53M | 36.53M | 36.27M | 36.12M | 33.65M | 32.28M | 33.98M | 30.09M | 32.71M | 23.36M | 22.93M | 22.39M | 24.25M | 26.43M | 14.09M | 10.81M | 9.16M | 7.45M | 6.7M | 5.87M |
| Selling, General, and Administrative Revenue Growth | -3.14% | -17.18% | -5.17% | -0.13% | -10.95% | +0.72% | +0.43% | +7.33% | +4.27% | -5.02% | +12.95% | -8.02% | +40.06% | +1.87% | +2.37% | -7.64% | -8.26% | +87.57% | +30.38% | +17.98% | +23.00% | +11.23% | +14.01% | n/a |
| Research and Development Revenue | 7.89M | 8.14M | 9.73M | 12.63M | 12.53M | 16.08M | 14.91M | 13.79M | 11.44M | 13.06M | 13.52M | 10.83M | 11.41M | 9.73M | 8.03M | 7.57M | 7.78M | 9.18M | 6.05M | 5.84M | 6.63M | 5.71M | 5.58M | 5.41M |
| Research and Development Revenue Growth | -3.07% | -16.39% | -22.96% | +0.82% | -22.05% | +7.85% | +8.07% | +20.53% | -12.37% | -3.42% | +24.84% | -5.07% | +17.28% | +21.13% | +6.10% | -2.75% | -15.16% | +51.58% | +3.68% | -11.93% | +16.14% | +2.24% | +3.26% | n/a |
| Sales and Marketing Revenue | 15.45M | 15.42M | 18.13M | 21.05M | 22.19M | 24.72M | 24.98M | 24.33M | 23.63M | 22.28M | 23.2M | 20.38M | 22.99M | 15.73M | 13.2M | 13.15M | 15.2M | 13.34M | 9.24M | 7.28M | 6.88M | 5.01M | 4.51M | 3.86M |
| Sales and Marketing Revenue Growth | +0.22% | -14.95% | -13.87% | -5.16% | -10.22% | -1.06% | +2.68% | +2.97% | +6.08% | -3.97% | +13.84% | -11.37% | +46.20% | +19.10% | +0.42% | -13.48% | +13.89% | +44.35% | +26.94% | +5.80% | +37.41% | +11.06% | +16.93% | n/a |